AGIOS PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Goddard Glenn | Senior Vice President, Finance | Option Exercise | 6,000 | $0.47 | $2,820 | 6,000 | Feb 10, 2014 |
| Biller Scott | Chief Scientific Officer | Option Exercise | 6,000 | $0.47 | $2,820 | 6,000 | Feb 3, 2014 |
| Higgons John Duncan | Chief Operating Officer | Sale | 8,000 | $25.97 | $207,760 | 109,090 | Feb 3, 2014 |
| Goddard Glenn | Senior Vice President, Finance | Option Exercise | 7,000 | $0.47 | $3,290 | 7,000 | Jan 27, 2014 |
| Goddard Glenn | Senior Vice President, Finance | Sale | 10,000 | $34.71 | $347,100 | — | Jan 21, 2014 |
| Higgons John Duncan | Chief Operating Officer | Sale | 12,000 | $34.71 | $416,520 | 109,090 | Jan 21, 2014 |
| Biller Scott | Chief Scientific Officer | Sale | 6,000 | $34.71 | $208,260 | — | Jan 21, 2014 |
| Flagship Ventures Fund 2007, L.P. | — | C | 3,860,738 | — | — | 3,860,738 | Jul 29, 2013 |
| STARR KEVIN P | — | C | 5,018,960 | — | — | 5,564,414 | Jul 29, 2013 |
| NELSEN ROBERT | — | C | 3,860,738 | — | — | 3,860,738 | Jul 29, 2013 |
| Third Rock Ventures GP, L.P. | — | C | 5,018,960 | — | — | 5,564,414 | Jul 29, 2013 |
| BYBEE CLINTON | — | C | 3,860,738 | — | — | 3,860,738 | Jul 29, 2013 |
| CELGENE CORP /DE/ | — | C | 1,887,473 | — | — | 1,887,473 | Jul 29, 2013 |
| MARAGANORE JOHN | — | Purchase | 8,333 | $18.00 | $149,994 | 44,333 | Jul 24, 2013 |
| Tessier-Lavigne Marc | — | Purchase | 55,555 | $18.00 | $999,990 | 101,009 | Jul 24, 2013 |